✦ LIBER ✦

An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer

✍ Scribed by F. Caponigro; D. Lacombe; C. Twelves; J. Bauer; A.-S. Govaerts; S. Marréaud; A. Milano; A. Anthoney

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacokinetics of oxaliplatin

✍ Hea-Kyoung Cho; Eun-Sook Lee; Jung-Won Lee; Jong-Kook Park; Jin-Hyoung Kang; Kyu 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 244 KB

Clinical study of combining chemotherapy

✍ Yuanjue Sun; Hui Zhao; Yaowu Guo; Feng Lin; Lina Tang; Yang Yao 📂 Article 📅 2009 🏛 Springer-Verlag ⚖ 352 KB

Front-line Bevacizumab in combination wi

✍ Christos Emmanouilides; Georgia Sfakiotaki; Nikolaos Androulakis; Kostas Kalbaki 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 263 KB

Alpha-interferon in combination with 5-f

✍ C. J. A. Punt; P. H. M. Mulder; J. Th. M. Burghouts; D. J. Th. Wagener 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 331 KB

A phase I study of 5-fluorouracil, leuco

✍ Charles D. Blanke; Nora C. Mattek; Thomas G. Deloughery; Dennis R. Koop 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Phase I study of gefitinib, irinotecan,

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB